Ascendis Pharma A/S (ASND)

USD 135.7

(-3.28%)

Annual Balance Sheets

(In EUR)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 825.58 Million 1.08 Billion 1.08 Billion 979.79 Million 676.73 Million 318.96 Million
Total Current Assets 702.72 Million 923.47 Million 805.88 Million 740.13 Million 611.16 Million 292.9 Million
Cash And Short Term Investments 399.43 Million 735.45 Million 682.06 Million 718.79 Million 598.1 Million 277.86 Million
Cash and Cash Equivalents 392.16 Million 444.76 Million 446.26 Million 584.51 Million 598.1 Million 277.86 Million
Short Term Investments 7.27 Million 290.68 Million 235.79 Million 134.27 Million - -
Net Receivables 55.77 Million 25.62 Million 23.18 Million 7.34 Million 5.41 Million 2.63 Million
Inventory 208.93 Million 130.67 Million 75.4 Million 1.00 -3.00 1.00
Other Current Assets 38.57 Million 31.71 Million 25.23 Million 13.99 Million 7.64 Million 12.41 Million
Total Non-Current Assets 122.86 Million 166.26 Million 279.03 Million 239.66 Million 65.56 Million 26.06 Million
Net PPE 110.63 Million 129.09 Million 126.04 Million 108.11 Million 45.06 Million 4.32 Million
Good Will And Intangible Assets 4.41 Million 4.82 Million 5.27 Million 5.71 Million 3.49 Million 3.49 Million
Good Will 3.49 Million 3.49 Million 3.49 Million 3.49 Million 3.49 Million 3.49 Million
Intangible Assets 924 Thousand 1.33 Million 1.77 Million 2.22 Million - -
Long-Term Investments 5.68 Million 30.42 Million 145.9 Million 124.45 Million 15.53 Million 17.08 Million
Tax Assets - - - - - -
Other Non Current Assets 2.12 Million 1.92 Million 1.8 Million 1.37 Million 1.46 Million 1.15 Million
Other Assets - - - - - -
Total Liabilities 971.28 Million 826.39 Million 201.28 Million 141.08 Million 79.61 Million 38.91 Million
Total Current Liabilities 197.34 Million 171.27 Million 100.35 Million 52.8 Million 47.99 Million 38.91 Million
Account Payables 94.56 Million 101.03 Million 59.41 Million 21.89 Million 27.76 Million 19.74 Million
Tax Payables 2.29 Million 5.49 Million 198 Thousand 301 Thousand 119 Thousand 9000.00
Short Term Debt 25.4 Million 25.42 Million 6.99 Million 6.85 Million 5.89 Million -
Deferred Revenue 1.18 Million - 2.6 Million 363 Thousand 858 Thousand 6.9 Million
Other Current Liabilities 76.19 Million 44.81 Million 31.34 Million 23.68 Million 13.46 Million 12.27 Million
Total Non Current Liabilities 773.94 Million 655.11 Million 100.93 Million 88.27 Million 31.62 Million 26.64 Million
Long-Term Debt 618.86 Million 482.95 Million 97.96 Million 85.11 Million 30.72 Million -
Deferred Revenue Non Current 5.94 Million 14.21 Million 2.96 Million - - -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 143.29 Million 157.95 Million 2.96 Million 3.16 Million 908 Thousand 26.64 Million
Other Liabilities - - - - - -26.64 Million
Total Equity -145.69 Million 263.34 Million 883.63 Million 838.71 Million 597.11 Million 280.05 Million
Stock Holders Equity -145.69 Million 263.34 Million 883.63 Million 838.71 Million 597.11 Million 280.05 Million
Common Stock 7.74 Million 7.67 Million 7.64 Million 7.21 Million 6.44 Million 5.65 Million
Retained Earnings -2.27 Billion -1.85 Billion -1.41 Billion -1.03 Billion -611.32 Million -393.3 Million
Accumulated other comprehensive income -153.44 Million 255.67 Million 875.98 Million 831.49 Million 590.67 Million 274.39 Million
Common Stock Equity -145.69 Million 263.34 Million 883.63 Million 838.71 Million 597.11 Million 280.05 Million
Capital Lease Obligation 98.79 Million 109.19 Million 104.96 Million 91.97 Million 36.61 Million -
Total Investments 12.96 Million 321.11 Million 381.7 Million 258.73 Million 15.53 Million 17.08 Million
Total Debt 644.26 Million 508.37 Million 104.96 Million 91.97 Million 36.61 Million -
Net Debt 252.1 Million 63.61 Million -341.3 Million -492.54 Million -561.48 Million -277.86 Million

Balance Sheet Charts